Abstract
Enzyme inhibitors are pivotal in the development of therapeutic agents across various medical disciplines. By modulating enzyme activity, these compounds can regulate metabolic pathways and treat a range of diseases, including cardiovascular disorders, cancer, and infectious diseases. This article explores the classification, mechanisms, and biomedical applications of enzyme inhibitors, with a focus on their role in drug development and clinical therapy. It also addresses the challenges associated with inhibitor specificity, resistance, and toxicity, while proposing future directions in the design of novel enzyme-targeting drugs.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.